domingo, 19 de enero de 2025

FDA Approves New ADC for HR+, HER2- Breast Cancer Sharon Worcester, MA January 17, 2025

https://www.medscape.com/viewarticle/fda-approves-new-adc-hr-her2-breast-cancer-2025a100017n

No hay comentarios:

Publicar un comentario